The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

The Brii Biosciences-backed lung disease treatment developer priced an upsized offering in the middle of its range.

Amgen Ventures and existing backers GV, Heritage Provider Network and Alexandria Venture Investments helped the cancer and IBD drug developer secure fresh funding.

Hikma Ventures co-led the telehealth platform developer’s oversubscribed series B round, which will help it move into the digital pharmacy market.

Industrial data software producer OnePredict closed a $25m GS Energy-backed series C round while several corporates helped drone infrastructure provider Skyports raise $23m.

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

The surgical training technology developer boosted plans to expand its technology with backing from Kaiser Permanente, taking its total funding to $109m.

The co-founders of Fred Hutch's oncology therapeutics developer include Philip Greenberg who previously helped launch Juno Therapeutics.

The molecular drug developer received funding from investors including GlaxoSmithKline, MRL Ventures Fund and GV in a Fidelity-led series C round.

Hikma led a $15m extension to surgical robotics developer Activ Surgical's series B round, now sized at $60m, while data collaboration software provider Hex raised $52m from investors including Snowflake and Databricks.